1 August 2019 in Radiology
CT image conversion using a convolutional neural network can reduce the effect of different reconstruction kernels on radiomic parameters. This will facilitate comparison of image features derived ... Background Intratumor heterogeneity in lung cancer may influence outcomes. CT radiomics seeks to assess tumor features to provide detailed imaging features. However, CT radiomic features vary accor...
1 January 2022 in Radiology
The proposed content-based image retrieval system is expected to assist in the diagnosis of interstitial lung disease in clinical practice regardless of experience level. Background Evaluation of interstitial lung disease (ILD) at CT is a challenging task that requires experience and is subject to substantial interreader variability. Purpose To investigate whether a...
1 January 2019 in Korean Journal of Radiology
Choe J, et al. Korean J Radiol. 2019 Jan;20(1):5-17. https://doi.org/10.3348/kjr.2018.0040
15 October 2023 in American Journal of Respiratory and Critical Care Medicine
Rationale: The optimal follow-up computed tomography (CT) interval for detecting the progression of interstitial lung abnormality (ILA) is unknown. Objectives: To identify optimal follow-up strategies and extent thresholds on CT relevant to outcomes. Methods: This retrospective study included self-referred screening participants aged 50 years or older, including nonsmokers, who had imaging findings relevant to ILA on chest CT scans. Consecutive CT scans were evaluated to determine the dates of the initial CT showing ILA and the CT showing progression. Deep learning–based ILA quantification was performed. Cox regression was used to identify risk factors for the time to ILA progression and progression to usual interstitial pneumonia (UIP). Measurements and Main Results: Of the 305 participants with a median follow-up duration of 11.3 years (interquartile range, 8.4–14.3 yr), 239 (78.4%) had ILA on at least one CT scan. In participants with serial follow-up CT studies, ILA progression was observed in 80.5% (161 of 200), and progression to UIP was observed in 17.3% (31 of 179), with median times to progression of 3.2 years (95% confidence interval [CI], 3.0–3.4 yr) and 11.8 years (95% CI, 10.8–13.0 yr), respectively. The extent of fibrosis on CT was an independent risk factor for ILA progression (hazard ratio, 1.12 [95% CI, 1.02–1.23]) and progression to UIP (hazard ratio, 1.39 [95% CI, 1.07–1.80]). Risk groups based on honeycombing and extent of fibrosis (1% in the whole lung or 5% per lung zone) showed significant differences in 10-year overall survival (P = 0.02). Conclusions: For individuals with initially detected ILA, follow-up CT at 3-year intervals may be appropriate to monitor radiologic progression; however, those at high risk of adverse outcomes on the basis of the quantified extent of fibrotic ILA and the presence of honeycombing may benefit from shortening the interval for follow-up scans.
1 July 2020 in RadioGraphics
Editor's Note.-Articles in the RadioGraphics Update section provide current knowledge to supplement or update information found in full-length articles previously published in RadioGraphics. Authors of the previously published article provide a brief synopsis that emphasizes important new information such as technological advances, revised imaging protocols, new clinical guidelines involving imaging, or updated classification schemes. Articles in this section are published solely online and are linked to the original article.